"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...

Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded ...

Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Eli Lilly has raised its revenue guidance for 2024 ... The performance of both drugs was way ahead of forecasts. "US demand for Mounjaro and Zepbound is strong and growing as access and supply ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...